{
    "2020-08-14": [
        [
            {
                "time": "",
                "original_text": "被卖水耽误的「广告公司」，农夫山泉上市后还能甜多久？| 超级观点",
                "features": {
                    "keywords": [
                        "农夫山泉",
                        "广告",
                        "上市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费品",
                        "广告"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物(603392.SH)：冻干水痘减毒活疫苗IIa临床试验获得伦理审查批件和CDE药物临床试验登记与信息公示平台公示文件",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "冻干水痘减毒活疫苗",
                        "临床试验",
                        "伦理审查",
                        "CDE"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：研发的冻干水痘减毒活疫苗获伦理审查批件",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "冻干水痘减毒活疫苗",
                        "伦理审查"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块再跌超2%，复星医药、万泰生物均跌5%左右",
                "features": {
                    "keywords": [
                        "疫苗板块",
                        "下跌",
                        "复星医药",
                        "万泰生物"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝尔生物拟创业板上市：业绩增长较为稳健，商誉减值压力犹存",
                "features": {
                    "keywords": [
                        "贝尔生物",
                        "创业板",
                        "上市",
                        "业绩增长",
                        "商誉减值"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}